TotalMarketCap

Genelux

GNLXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$82.347 M

$1.82 -7.14%

Close of 6 Nov 2026

As of 6 Nov 2026, Genelux (GNLX) has a market capitalization of $82.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$8.00K

#3604 by revenue

Earnings

-$32.1M

Loss-making

Shares outstanding

45,245,335

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #301RallybioRLYB$84.7M
  2. #302Retension PharmaceuticalsRTSN$83.4M
  3. #303GeneluxGNLX$82.3M
  4. #304Tiziana Life SciencesTLSA$79.3M
  5. #305Tonix PharmaceuticalsTNXP$79.0M

What if Genelux were worth as much as…

Open the what-if tool →

Gold $28.2T

$624,083.65

Per share 342,903× higher

Bitcoin $1.53T

$33,768.08

Per share 18,554× higher

Apple $5.02T

$110,857.45

Per share 60,911× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Genelux are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.